CVS Health Corporation
CVS Health Corporation (CVS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CVS · as of Mar 31, 2025
Ownership Breakdown
1,845
Institutional Holders
▲ 81 vs Q4
$73.35B
Total Inst. Value
▲ $26.32B vs Q4
1.28B
Shares Outstanding
freeFloat 99.79%
1.08B
13F Shares Held
▲ 35.54M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CVS largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC retail-drug stores and proprietary stores | 118.34M | 9.38% | 9.38% | $8.02T | May 9, 2025 | ▲ 969.0K |
BLACKROCK, INC. retail-drug stores and proprietary stores | 112.59M | 8.93% | 8.93% | $7.63T | May 2, 2025 | ▲ 6.63M |
DODGE & COX retail-drug stores and proprietary stores | 73.46M | 5.83% | 5.83% | $4.98T | May 14, 2025 | ▲ 3.35M |
CAPITAL WORLD INVESTORS retail-drug stores and proprietary stores | 68.40M | 5.42% | 5.42% | $4.63T | May 12, 2025 | ▲ 7.36M |
STATE STREET CORP retail-drug stores and proprietary stores | 57.99M | 4.60% | 4.60% | $3.93T | May 15, 2025 | ▲ 1.04M |
FMR LLC retail-drug stores and proprietary stores | 30.89M | 2.45% | 2.45% | $2.09T | May 12, 2025 | ▲ 2.76M |
GEODE CAPITAL MANAGEMENT, LLC retail-drug stores and proprietary stores | 27.96M | 2.22% | 2.22% | $1.89T | May 13, 2025 | ▲ 907.9K |
CAPITAL INTERNATIONAL INVESTORS retail-drug stores and proprietary stores | 26.19M | 2.08% | 2.08% | $1.77T | May 12, 2025 | ▼ 478.7K |
JPMORGAN CHASE & CO retail-drug stores and proprietary stores | 23.44M | 1.86% | 1.86% | $1.59T | May 12, 2025 | ▲ 9.54M |
INVESCO LTD. retail-drug stores and proprietary stores | 20.41M | 1.62% | 1.62% | $1.38T | May 12, 2025 | ▲ 2.38M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
30
Increased
+79.36M shares0
New Positions
first time holders19
Decreased
−25.61M shares0
Sold Out
fully exitedNet shares change (top 50)
+53.76M
+79.36M / −25.61M
Net new holders
+11
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CVS insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
12
Buy transactions
20
Sell transactions
0.60
Buy/Sell ratio
$4M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Newman Brian EVP, Chief Financial Officer | May 31, 2026 | Tax Withhold | 2,478 | $90.98 | $225.4K | 3.0K | Form 4 ↗ |
Compton-Phillips Amy EVP, Chief Medical Officer | May 31, 2026 | Tax Withhold | 7,618 | $90.98 | $693.1K | 9.6K | Form 4 ↗ |
AGUIRRE FERNANDO director | May 20, 2026 | D-Return | 30,437 | $93.78 | $2.85M | 12.1K | Form 4 ↗ |
AGUIRRE FERNANDO director | May 21, 2026 | D-Return | 1,563 | $93.50 | $146.1K | 10.5K | Form 4 ↗ |
ROBBINS LARRY director | May 19, 2026 | Sale | 1,983,387 | $94.45 | $187.33M | 6.21M | Form 4 ↗ |
ROBBINS LARRY director | May 19, 2026 | Sale | 151 | $95.18 | $14.4K | 6.21M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 797,628 | $93.48 | $74.56M | 5.42M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 152,691 | $94.81 | $14.48M | 5.26M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 66,881 | $95.67 | $6.40M | 5.20M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 800 | $96.28 | $77.0K | 5.20M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CVS Health Corporation (CVS) is primarily owned by institutional investors, who hold approximately 84.9% of total shares outstanding. Company insiders own approximately 0.21%, while retail and public investors account for the remaining 14.94%.
The largest institutional shareholder of CVS Health Corporation is VANGUARD GROUP INC, holding approximately 118.34 million shares — equal to 9.38% of outstanding shares — as of March 31, 2025.
A total of 1,845 institutional investors currently hold CVS stock, with a combined institutional value of approximately $73.35 billion as of the most recent 13F filing period.
Frequently asked questions
CVS ownershipCVS Health Corporation (CVS) is primarily owned by institutional investors, who hold approximately 84.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.38% stake. Company insiders hold 0.21%. Data sourced from SEC Form 13F as of March 31, 2025.